Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1991 Oct;86(1):87–91. doi: 10.1111/j.1365-2249.1991.tb05778.x

Occurrence of lymphocytotoxins in multi-case rheumatoid arthritis families: relation to HLA.

V Taneja 1, N K Mehra 1, R R Singh 1, C Anand 1, A N Malaviya 1
PMCID: PMC1554146  PMID: 1914238

Abstract

The presence of lymphocytotoxic antibodies (LCA) and their association with HLA haplotypes has been studied in 27 multi-case rheumatoid arthritis (RA) families (13 multiplex and 14 simplex) in Northern India. Of the total 59 RA patients, 69.4% had cytotoxins in their sera as compared with 2.5% of healthy controls. No differences were observed in the frequency of LCA in relation to sex and rheumatoid factor. LCA against B cells were significantly more predominant than those against T cells. Twenty families studied for correlation of HLA with LCA showed greater intensity of reaction with DR4+ haplotypes, particularly in simplex families. Similarly, the frequency of LCA among patients and unaffected parents was greater in simplex compared with multiplex families. Haplotype sharing with the patient was increased in the relatives positive for cytotoxins in these families. An immunogenetic contribution made by the affected parent and a common environmental stimulus may be responsible for the increased production of LCA in multi-case families with RA.

Full text

PDF
87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Charlesworth J. A., Peake P., Campbell L. V., Rumma J., Pussell B. A., Howard N., Elder G. J. Detection of lymphocytotoxic antibodies in relatives of patients with type I diabetes. Br Med J (Clin Res Ed) 1986 Feb 1;292(6516):292–294. doi: 10.1136/bmj.292.6516.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dawkins R. L., Witt C., Richmond J., Sagenschneider K., Zilko P. J. Lymphocytotoxic antibodies in disease. Aust N Z J Med. 1978;8 (Suppl 1):81–86. doi: 10.1111/j.1445-5994.1978.tb04791.x. [DOI] [PubMed] [Google Scholar]
  4. DeHoratius R. J., Messner R. P. Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus. J Clin Invest. 1975 Jun;55(6):1254–1258. doi: 10.1172/JCI108044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hazelton R. A. A study of lymphocytotoxins in the sera of families of patients with rheumatoid disease. Arthritis Rheum. 1984 Feb;27(2):233–236. doi: 10.1002/art.1780270218. [DOI] [PubMed] [Google Scholar]
  6. Kreisler M. J., Hirata A. A., Terasaki P. I. Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination. Transplantation. 1970 Nov;10(5):411–415. [PubMed] [Google Scholar]
  7. Ozturk G., Terasaki P. I. Non-HLA lymphocyte cytotoxins in various diseases. Tissue Antigens. 1979 Jul;14(1):52–58. doi: 10.1111/j.1399-0039.1979.tb00821.x. [DOI] [PubMed] [Google Scholar]
  8. Sakane T., Steinberg A. D., Reeves J. P., Green I. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets. J Clin Invest. 1979 Nov;64(5):1260–1269. doi: 10.1172/JCI109581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Schocket A. L., Kohler P. F. Lymphocytotoxic antibodies in systemic lupus erythematosus and clinically related diseases. Arthritis Rheum. 1979 Oct;22(10):1060–1063. doi: 10.1002/art.1780221003. [DOI] [PubMed] [Google Scholar]
  10. Searles R. P., Okudaira K., Savage S. M., Goodwin J. S. Ia specific antilymphocyte antibodies in rheumatoid arthritis. Arthritis Rheum. 1983 Apr;26(4):486–493. doi: 10.1002/art.1780260406. [DOI] [PubMed] [Google Scholar]
  11. Steffen C., Thumb N., Frank O., Eberl R., Tausch G., Boros M. Demonstration of lymphocytotoxins in rheumatoid arthritis in comparison with clinical course and other antibody activities. Z Immunitatsforsch Exp Klin Immunol. 1973 Jun;145(4):303–311. [PubMed] [Google Scholar]
  12. TERASAKI P. I., MCCLELLAND J. D. MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964 Dec 5;204:998–1000. doi: 10.1038/204998b0. [DOI] [PubMed] [Google Scholar]
  13. Taneja V., Mehra N., Singh Y. N., Kumar A., Malaviya A., Singh R. R. HLA-D region genes and susceptibility to D-penicillamine-induced myositis. Arthritis Rheum. 1990 Sep;33(9):1445–1447. doi: 10.1002/art.1780330922. [DOI] [PubMed] [Google Scholar]
  14. Terasaki P. I., Mottironi V. D., Barnett E. V. Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med. 1970 Oct 1;283(14):724–728. doi: 10.1056/NEJM197010012831403. [DOI] [PubMed] [Google Scholar]
  15. Vasan R. S., Mehra N. K., Malaviya A. N., Chaudhuri T. K. Lymphocytotoxic antibodies in patients with systemic lupus erythematosus & their household contacts. Indian J Med Res. 1990 Jun;92:147–150. [PubMed] [Google Scholar]
  16. Vischer T. L., Jeannet M. Lymphocytotoxic antibodies in rheumatoid arthritis: relation to HLA-DR2 and rheumatoid factors. Clin Exp Rheumatol. 1986 Apr-Jun;4(2):139–142. [PubMed] [Google Scholar]
  17. Wooley P. H., Panayi G. S., Batchelor J. R. Lymphocytotoxins in rheumatoid arthritis: prevalence, lymphocyte specificity, and HLA-DR antigens. Ann Rheum Dis. 1981 Apr;40(2):154–156. doi: 10.1136/ard.40.2.154. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES